American Pharmacy News
  • People
  • Innovation
  • Regulatory
  • Industry
  • Federal Issues
  • State Issues
  • Directory
  • People
  • Innovation
  • Regulatory
  • Industry
  • Federal Issues
  • State Issues
  • Directory
  • Home
  • »
  • 2017
  • »
  • January

CVS head addresses investors at health care conference

American Pharmacy News Reports | Jan 11, 2017
Larry Merlo spoke to investors this week.
Larry Merlo spoke to investors this week. | Contributed photo
CVS Health Corp. President and CEO Larry Merlo spoke to investors this week at the 35th Annual J.P. Morgan Healthcare Conference.
An audio webcast of the event is available on the CVS website, under the Investor Relations section. 
The conference will continue through Friday in San Francisco.
More News

Those with preexisting health conditions may experience a different immune response to the COVID-19 vaccination.

People CDC releases COVID-19 guidance for those with health conditions Jan 10, 2021

Novavax is the latest COVID-19 vaccine to enter Phase III clinical trials.

Innovation Fifth vaccine set to enter Phase III clinical trials Jan 3, 2021

Regulatory CENTENE: Completes Acquisition of PANTHERx Rare Pharmacy (PANTHERx) Dec 31, 2020

Industry NHA: Creates Partnership, Path for Accredited Immunization Training for Pharmacy Technicians Ahead of New Vaccines Dec 31, 2020

Industry TRANQUILMONEY: Releases PharmTracker for Independent Pharmacies, Small and Medium Pharmacy Chains Dec 26, 2020

Industry MITSUBISHI TANABE PHARMA AMERICA: Announces Initiation of Open-Label Extension Study of Oral Edaravone in ALS Dec 22, 2020

Trending

Those with preexisting health conditions may experience a different immune response to the COVID-19 vaccination.

CDC releases COVID-19 guidance for those with health conditions

Copyright © 2024 American Pharmacy News. All Rights Reserved.

  • About
  • Contact
  • Privacy Policy
  • Terms of Service

Alerts Sign-up